Another potential approach to treat chemotherapy-induced hemorrhagic cystitis is to administer IL-412, a potent anti-inflammatory cytokine known to antagonize the IL-1β, TNFα and IL-6 pathways. The gene discussed is TNF; the disease is hemorrhagic cystitis.